FOR SUSPECTED ADVERSE REACTIONS please report to the Food and Drug Administration (Philippines) at www.fda.gov.ph and to the DISTRIPHIL Pharmacovigilance Unit through email address drugsafety@distriphil.com or  you may call or text our 24/7 Pharmacovigilance Hotline at +63-949-884-5386 (Smart). AT THE FIRST SIGN OF AN ADVERSE REACTION, PLEASE SEEK MEDICAL ATTENTION IMMEDIATELY.